First Horizon: Funding Cost Concerns Limit Upside

First Horizon (FHN) is rated a 'hold' near ~$25, citing solid credit quality but ongoing deposit mix and reserve concerns. The Q2 earnings beat is attributed more to a low tax rate than core operations, while NIM compressed and deposit growth leaned on expensive brokered funds, pressuring margins. Near-term pressure remains, though steady loan growth and manageable CRE/NDFI exposure provide some offset as loan repricing may support longer-term upside.

Analysis

The market should treat this as a funding-quality story, not a credit story. Expensive wholesale money is a tax on equity value because it caps near-term margin recovery even if the loan book behaves; that tends to matter most over the next 1-3 quarters, when investors are looking for proof that deposit costs have peaked. The low-tax-driven earnings beat is also low-conviction, so any multiple support from the quarter is fragile.

Relative winners are regional banks with sticky core deposits and less need to tap brokered funding; they can reprice assets into the same rate environment with less balance-sheet drag. In the Southeast, that puts pressure on FHN versus higher-quality franchises such as PNC, USB, and potentially SNV, while also making the broader regional bank complex more sensitive to any sign of deposit competition re-accelerating. The second-order effect is that if FHN keeps leaning on brokered funds, it may have to defend balance-sheet growth at the cost of NIM, which can slow tangible book accretion.

Contrarian view: the negative setup may be somewhat overdone if loan repricing lands faster than expected and reserve concerns remain contained. The key falsifier is a clear inflection in NIM and core deposit mix over the next 1-2 quarters; absent that, the stock likely remains range-bound rather than rerating. Over 6-18 months, the loan book can help, but only if funding costs normalize before credit costs reaccelerate.

Key Decisions for Investors

• Relative-value short FHN vs long PNC or USB for 1-3 months: thesis is funding-franchise quality should outperform as the market discounts margin compression.
• Do not chase an outright long in FHN until there is evidence of core deposit stabilization and brokered funding declines; otherwise risk/reward remains asymmetric to the downside.
• Set an alert on next-quarter NIM and deposit mix: if NIM fails to inflect while brokered funds stay elevated, use any bounce to reduce exposure or initiate a short.
• If holding a regional-bank basket (KRE), consider underweighting FHN within the basket; the idiosyncratic funding drag can cause underperformance versus peers even in a stable macro tape.